Millennium Management’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Buy |
248,423
+101,653
| +69% | +$82.3K | ﹤0.01% | 3701 |
|
|
2025
Q1 | $113K | Sell |
146,770
-315,785
| -68% | -$243K | ﹤0.01% | 3738 |
|
|
2024
Q4 | $590K | Buy |
462,555
+302,031
| +188% | +$385K | ﹤0.01% | 3183 |
|
|
2024
Q3 | $332K | Buy |
+160,524
| New | +$332K | ﹤0.01% | 3510 |
|
|
2024
Q2 | – | Sell |
-101,850
| Closed | -$483K | – | 4371 |
|
|
2024
Q1 | $483K | Buy |
101,850
+4,884
| +5% | +$23.2K | ﹤0.01% | 3316 |
|
|
2023
Q4 | $414K | Buy |
96,966
+33,099
| +52% | +$141K | ﹤0.01% | 3254 |
|
|
2023
Q3 | $197K | Sell |
63,867
-74,626
| -54% | -$231K | ﹤0.01% | 3615 |
|
|
2023
Q2 | $623K | Buy |
138,493
+1,974
| +1% | +$8.88K | ﹤0.01% | 3163 |
|
|
2023
Q1 | $778K | Buy |
136,519
+86,783
| +174% | +$495K | ﹤0.01% | 3206 |
|
|
2022
Q4 | $300K | Sell |
49,736
-10,690
| -18% | -$64.5K | ﹤0.01% | 3916 |
|
|
2022
Q3 | $399K | Sell |
60,426
-30,511
| -34% | -$201K | ﹤0.01% | 3994 |
|
|
2022
Q2 | $475K | Buy |
90,937
+51,626
| +131% | +$270K | ﹤0.01% | 3918 |
|
|
2022
Q1 | $271K | Sell |
39,311
-404,800
| -91% | -$2.79M | ﹤0.01% | 4495 |
|
|
2021
Q4 | $5.53M | Buy |
444,111
+403,260
| +987% | +$5.02M | ﹤0.01% | 2142 |
|
|
2021
Q3 | $1.28M | Buy |
40,851
+19,893
| +95% | +$622K | ﹤0.01% | 3431 |
|
|
2021
Q2 | $600K | Buy |
20,958
+7,455
| +55% | +$213K | ﹤0.01% | 4069 |
|
|
2021
Q1 | $585K | Buy |
+13,503
| New | +$585K | ﹤0.01% | 3572 |
|
|
2020
Q4 | – | Sell |
-189,573
| Closed | -$5.71K | – | 4328 |
|
|
2020
Q3 | $5.71K | Buy |
+189,573
| New | +$5.71K | 0.01% | 1330 |
|